Oxford Science Enterprises, an investment group partnered with the University of Oxford, has appointed Sanne de Jongh as partner, life sciences. She will be responsible for sourcing spin-out opportunities from the university as well as supporting the firm’s existing portfolio. Ms de Jongh joins from Gilde Healthcare where she was an investment manager focused on biotech companies. At Gilde, she also set up a fellowship programme to offer scientists a route from academia into venture capital. Ms de Jongh holds a bachelor of science degree in biochemistry from Leiden University, and a master of science in biochemical engineering from the Delft University of Technology, both in the Netherlands.
Oxford Science Enterprises announced the appointment on 7 February 2023.
Copyright 2023 Evernow Publishing Ltd